Search Articles

View query in Help articles search
e.g. mhealth

Search Results (1 to 2 of 2 Results)

Download search results: CSV END BibTex RIS

Google Search Trends About Systemic Psoriasis Treatment: What Do People Want to Know About Biologics and Janus Kinase Inhibitors?

Google Search Trends About Systemic Psoriasis Treatment: What Do People Want to Know About Biologics and Janus Kinase Inhibitors?

Adalimumab exhibited the highest search volume among all medications (RSV 1). Apremilast was the most searched among small molecule inhibitors and methotrexate among disease-modifying antirheumatic drugs (RSV 1).

Subin Lim, Sarah Kooper-Johnson, Courtney A Chau, Claire Chen, Fei-Shiuann Clarissa Yang, Gabriela Cobos

JMIR Dermatol 2024;7:e62948

Download Citation: END BibTex RIS

Download PDF Download XML
Article has an altmetric score of 8

Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

Immunomodulators such as thiopurines (azathioprine [AZA] or 6-mercaptopurine [6-MP]), methotrexate (MTX), and biologicals such as adalimumab (ADA) are well established for the maintenance of remission in pediatric Crohn disease (CD). However, it remains unclear which maintenance medication should be used first line in specific patient groups.

Mattias Neyt, Annick Christiaens, Marina Aloi, Lissy de Ridder, Nicholas M Croft, Sibylle Koletzko, Arie Levine, Dan Turner, Richard K Russell, Frank M Ruemmele, Gigi Veereman

JMIR Form Res 2021;5(1):e13888

Download Citation: END BibTex RIS

Download PDF Download XML
Article has an altmetric score of 2